Table 1

Clinical characteristics of each sample used in scRNA-seq study and the cell number of each sample after quality control

SampleAgeSexHistopathological diagnosisSite of originLauren's classification Helicobacter pylori EBERNumber of cell
Tumour samples used in scRNA-seq study
 DGC54FPoorly differentiated adenocarcinomaCardiaDiffuse3026
 IGC167FModerately poorly differentiated adenocarcinomaAngular incisureIntestinal+952
 IGC265MModerately differentiated adenocarcinomaCardiaIntestinal2616
 IGC356MModerately differentiated adenocarcinomaCardiaIntestinal2136
 IGC474MModerately poorly differentiated adenocarcinomaGreater curvatureIntestinal+2141
 IGC572MModerately poorly differentiated adenocarcinomaAngular incisureIntestinal+2695
 MGC156MPoorly differentiated adenocarcinomaAntrumMixed881
 MGC263MPoorly differentiated adenocarcinomaAngular incisureMixed2405
 MGC362MPoorly differentiated adenocarcinoma, partial signet ring cell carcinomaAngular incisureMixed+3318
Non-tumour samples used in scRNA-seq study
 CG53FChronic gastritisCardiaN/A+3568
 NC138MNormalGreater curvatureN/A1773
 NC243FNormalGreater curvatureN/A2166
  • EBER, EBV-encoded RNA; N/A, not available.